AAT Recombinant Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Inhibitor of serine proteases. Its primary target is elastase, but it also has a moderate affinity for plasmin and thrombin. Irreversibly inhibits trypsin, chymotrypsin and plasminogen activator. The aberrant form inhibits insulin-induced NO synthesis in platelets, decreases coagulation time and has proteolytic activity against insulin and plasmin.
Synonyms
Serpin A1; Short peptide from AAT; SPAAT; AAT.
Gene ID
5265
Swiss Prot
P01009
Cellular Locus
Extracellular, Secreted
Host
Rabbit
Cross Reactivity
Human
Target
AAT
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human Antithrombin 3
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5265
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
E3452-45F-PE 100 µL
ERK1 (Extracellular Signal-regulated Kinase 1, ERK-1, Esrk1, ERT2, Insulin-stimulated MAP2 Kinase, MAP Kinase Isoform p44, Mitogen-activated Protein Kinase 3, MAP Kinase 3, MAPK 3, Mapk3, Mitogen-activated Protein Kinase 1, MAP Kinase 1, MAPK 1, MAPK1, Microtubule-associated Protein 2 Kinase, MNK1, p44, p44erk1, p44-ERK1, p44mapk, p44-MAPK, Prkm3) (PE)
Ask
View Details